JESSIE MILES: Open Payments
NPI 1619983350 · GOODYEAR, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$218 in 10 payments from 8 companies in 2025. Trend: 2023 $349 · 2024 $736 · 2025 $218
Food & beverage: $218
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $61 |
| AstraZeneca Pharmaceuticals LP | 1 | $32 |
| ABBVIE INC. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| GENZYME CORPORATION | 1 | $24 |
| Adaptive Biotechnologies Corporation | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Karyopharm Therapeutics Inc. | 1 | $15 |
Products named: KISQALI, EPKINLY, Fabhalta, ALUNBRIG, SARCLISA, clonoSEQ, Enhertu, XPOVIO.
Industry payments across AZ — which companies pay providers there.
